Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Isabel Lucena

Showing results (101-110 of 152) with videos related to

Pageof 16
Sort By:
Journal of Hepatology|May 20, 2008
Analysis of IL-10, IL-4 and TNF-alpha polymorphisms in drug-induced liver injury (DILI) and its outcomeKetevan Pachkoria, M Isabel Lucena, Esperanza Crespo, et al.
Clinical Pharmacology and Therapeutics|September 20, 2021
Lymphocyte Profile and Immune Checkpoint Expression in Drug-Induced Liver Injury: An Immunophenotyping StudyAlejandro Cueto-Sanchez, Hao Niu, Enrique Del Campo-Herrera, et al.
Clinical Pharmacology and Therapeutics|August 2, 2017
Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen LocusMia Wadelius, Niclas Eriksson, Reinhold Kreutz, et al.
Pharmacological Research|July 11, 2022
Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injuryCristina Rodriguez-Diaz, Bernard Taminiau, Alberto García-García, et al.
United European Gastroenterology Journal|July 19, 2019
Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature reviewMiguel Eugenio Zoubek, José Pinazo-Bandera, Aida Ortega-Alonso, et al.
Antioxidants (Basel, Switzerland)|April 28, 2023
Membrane Vesicles of Toxigenic <i>Clostridioides difficile</i> Affect the Metabolism of Liver HepG2 CellsEstefanía Caballano-Infantes, Ailec Ho-Plágaro, Carlos López-Gómez, et al.
Hepatology (Baltimore, Md.)|September 29, 2006
Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from SpainM Isabel Lucena, Raúl J Andrade, M Carmen Fernández, et al.
Gastroenterology|April 8, 2014
Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injuryMercedes Robles-Diaz, M Isabel Lucena, Neil Kaplowitz, et al.
Clinical Pharmacology and Therapeutics|November 12, 2020
Clinical Characteristics and Outcome of Drug-Induced Liver Injury in the Older Patients: From the Young-Old to the Oldest-OldRianne A Weersink, Ismael Alvarez-Alvarez, Inmaculada Medina-Cáliz, et al.
British Journal of Clinical Pharmacology|March 25, 2023
Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damageAlejandro Cueto-Sánchez, Hao Niu, Ismael Álvarez-Álvarez, et al.
Pageof 16

Showing results (101-110 of 152) with videos related to

Sort By:
Pageof 16
Journal of Hepatology|May 20, 2008
Analysis of IL-10, IL-4 and TNF-alpha polymorphisms in drug-induced liver injury (DILI) and its outcomeKetevan Pachkoria, M Isabel Lucena, Esperanza Crespo, et al.
Clinical Pharmacology and Therapeutics|September 20, 2021
Lymphocyte Profile and Immune Checkpoint Expression in Drug-Induced Liver Injury: An Immunophenotyping StudyAlejandro Cueto-Sanchez, Hao Niu, Enrique Del Campo-Herrera, et al.
Clinical Pharmacology and Therapeutics|August 2, 2017
Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen LocusMia Wadelius, Niclas Eriksson, Reinhold Kreutz, et al.
Pharmacological Research|July 11, 2022
Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injuryCristina Rodriguez-Diaz, Bernard Taminiau, Alberto García-García, et al.
United European Gastroenterology Journal|July 19, 2019
Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature reviewMiguel Eugenio Zoubek, José Pinazo-Bandera, Aida Ortega-Alonso, et al.
Antioxidants (Basel, Switzerland)|April 28, 2023
Membrane Vesicles of Toxigenic <i>Clostridioides difficile</i> Affect the Metabolism of Liver HepG2 CellsEstefanía Caballano-Infantes, Ailec Ho-Plágaro, Carlos López-Gómez, et al.
Hepatology (Baltimore, Md.)|September 29, 2006
Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from SpainM Isabel Lucena, Raúl J Andrade, M Carmen Fernández, et al.
Gastroenterology|April 8, 2014
Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injuryMercedes Robles-Diaz, M Isabel Lucena, Neil Kaplowitz, et al.
Clinical Pharmacology and Therapeutics|November 12, 2020
Clinical Characteristics and Outcome of Drug-Induced Liver Injury in the Older Patients: From the Young-Old to the Oldest-OldRianne A Weersink, Ismael Alvarez-Alvarez, Inmaculada Medina-Cáliz, et al.
British Journal of Clinical Pharmacology|March 25, 2023
Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damageAlejandro Cueto-Sánchez, Hao Niu, Ismael Álvarez-Álvarez, et al.
Pageof 16